Jessie J's Breast Cancer: What Early-Stage Detection Really Means

What she said, and when

On 4 June 2025, ABC News reported that the English pop singer Jessie J had been diagnosed with breast cancer. She shared the news herself in an Instagram video the previous day.

Her own emphasis was on one word. "I'm highlighting the word 'early,'" she said. "Cancer sucks in any form, but I'm holding on to the word 'early,'"

She said she would perform in the United Kingdom on 15 June and then step away to have surgery, and explained her reason for going public: sharing in the past had brought her love, support and other people's own stories.

That is what she chose to make public, and this page goes no further. Everything below is about the disease, not about her care.

What "early" is doing in that sentence

It is not a casual word. In breast cancer it points at a specific distinction.

NCI describes breast cancer as starting in the breast, when cells grow without control and form a tumor that may spread elsewhere. It can begin in the milk ducts, in the lobules that make milk, in the fibrous and fatty tissue between them, in the nipple, or in blood and lymph vessels. Cancers starting in the ducts are ductal; those in the lobules are lobular. Most are ductal.

The line that matters here is this one. When abnormal cells are still inside the ducts or lobules and have not spread into other breast tissue, it is called carcinoma in situ. Cancers that have grown into the surrounding breast tissue are invasive, and NCI notes most breast cancers are invasive.

"Early" usually means the cancer has not spread far. It does not identify a type, a grade, or a treatment.

How a stage is actually assigned

NCI describes two kinds of staging, and the difference explains why a number can change.

Clinical prognostic staging comes first, for everyone diagnosed. It uses health history, physical examination, imaging including mammography or ultrasound of the lymph nodes, and biopsy findings.

Pathological prognostic staging applies only to people whose first treatment is surgery. It uses all the clinical information plus biomarker status and laboratory results from breast tissue and lymph nodes removed during the operation.

Both assign a number from 0 to IV, built from three things: the TNM value, the grade, and the biomarker status.

TNM covers the size and location of the tumor, which lymph nodes are involved and how much cancer is in them, and whether the cancer has spread elsewhere.

Grade describes how abnormal the cells look and how fast they are likely to grow. A pathologist scores three features from 1 to 3: how much of the tissue still has normal breast ducts, the size and shape of the nuclei, and how many cells are dividing.

Biomarker status covers hormone receptors and HER2 levels. Results from multigene tests may also feed in. Our page on breast cancer stages works through what each number involves.

Two people can both have "early" breast cancer and receive entirely different treatment, because grade and biomarkers differ.

When to get checked

NCI's framing is worth keeping: most breast changes are not cancer, and it is still important to check unusual ones.

The changes NCI lists are:

• A lump in or near the breast, a lump under the arm, or a thick or firm area in either place.
• A change in the size or shape of a breast.
• Fluid or discharge that is not breast milk.
• A change in the shape of the nipple, the direction it points, or a nipple that flattens.
• Scaly or swollen skin on the breast, nipple or areola.
• Redness or darkening of that skin.
• Itching or tingling in the nipple or areola.
• General swelling, with no lump necessarily present.
• A skin rash, or dimples and puckering.

NCI adds something people get wrong: breast cancer does not usually cause pain. Cysts, hormonal changes before a period and some medicines do. Persistent breast pain is still worth seeing a doctor about.

Screening covers the rest. The US Preventive Services Task Force recommends screening mammography every two years for women aged 40 to 74, a grade B recommendation. Since early breast cancer often causes no symptoms at all, that is how many cases like the "early" one described here are found. Our page on breast cancer symptoms covers what happens after a change is reported.

What the numbers say about early disease

The projection of 321,910 new US female breast cancer cases and 42,140 deaths for 2026 is the American Cancer Society's, published on SEER. Median age at diagnosis, an NCI measurement, is 64.

Five-year relative survival for cases from 2016 to 2022 is 91.9 percent overall. Split by spread at diagnosis, it is 100.0 percent while the cancer is confined to the breast, 87.5 percent once regional lymph nodes are involved, and 33.8 percent for distant disease.

Sixty-four percent are found while still localized. Six percent are already distant.

That first figure is why the word early carries weight. It is also a group statistic drawn from hundreds of thousands of records, describing a population and not any individual. It cannot forecast one person's course, and it says nothing about someone with a particular subtype.

What this does not mean

A public statement is not a medical record. Type, grade, receptor status and treatment plan are private, and nothing here infers them.

One person's early diagnosis is not a template. Two people with the same stage can need different treatments and have different outcomes.

Age is worth noting in the other direction. Breast cancer mostly affects women aged 45 and older, and NCI says anyone with breasts can get it, including men, though that is rare. A younger diagnosis does not change what anyone else should do.

And celebrity disclosure changes awareness, not risk. The useful response is knowing what is normal for your own body and reporting changes, and knowing when screening starts.

Sources

• ABC News, Jessie J reveals breast cancer diagnosis, plans for surgery, 4 June 2025 — https://abcnews.go.com/GMA/Culture/jessie-reveals-breast-cancer-diagnosis-plans-surgery/story?id=122509866
• NCI, What Is Breast Cancer? — https://www.cancer.gov/types/breast/what-is-breast-cancer
• NCI, Signs and Symptoms of Breast Cancer — https://www.cancer.gov/types/breast/symptoms
• NCI, Breast Cancer Stages — https://www.cancer.gov/types/breast/stages
• US Preventive Services Task Force, Breast Cancer: Screening — https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
• SEER Cancer Stat Facts, Female Breast Cancer — https://seer.cancer.gov/statfacts/html/breast.html

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us